Zirabev 100 mg/4mL
bevacizumab-bvzr · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
Zirabev is a injection, solution containing bevacizumab-bvzr at 100 mg/4mL, taken intravenous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Zirabev
- Generic Name
- bevacizumab-bvzr
- NDC Code (Product)
0069-0315- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761099
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 01/13/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Zirabev used for?
Zirabev contains bevacizumab-bvzr. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Zirabev a controlled substance?
Zirabev is not classified as a controlled substance by the DEA.
What is the generic name for Zirabev?
The generic name for Zirabev is bevacizumab-bvzr. There are no other listed brand versions of bevacizumab-bvzr.
What is the NDC code for Zirabev 100 mg/4mL?
The NDC (National Drug Code) for Zirabev 100 mg/4mL is 0069-0315, listed by Pfizer Laboratories Div Pfizer Inc.
Other Zirabev Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)